Medication Adherence among Drug-Resistant Tuberculosis (DR-TB) Patients at Universitas Indonesia Hospital
DOI:
https://doi.org/10.36497/jri.v44i3.775Keywords:
drug-resistant tuberculosis, level of adherence, hospitalAbstract
Background: Drug-resistant tuberculosis (TB-DR) is a deadly disease caused by infectious agents. Indonesia is one of the countries with the highest drug-resistant tuberculosis (TB-DR) rates in the world. The prevalence of tuberculosis cases in Depok City between 2019-2022 showed an increase in cases every year. This study aims to measure the level of adherence of drug-resistant tuberculosis (TB-DR) patients to their treatment using the Eight-Item Morisky Medication Adherence Scale (MMAS-8) questionnaire.
Methods: This study is an observational study using a cross-sectional study design, conducted from February 2024 to March 2024 at the University of Indonesia Hospital. Eighty-seven respondents participated in this study. Respondents completed the validated Indonesian version of the MMAS-8 questionnaire after signing informed consent forms.
Results: The results of the study showed that 50.6% of respondents had low adherence levels, 47.1% had moderate adherence levels, and 2.3% had high adherence levels. The data was then statistically analyzed using the SPSS version 29 statistical package with Chi-Square analysis, which resulted in a significant correlation (P<0.05) between adherence levels and gender.
Conclusion: There was a significant correlation between gender and respondent adherence. More than 50% of drug-resistant tuberculosis (TB-DR) patients at the University of Indonesia Hospital still have low adherence levels to their treatment.
Downloads
References
World Health Organization. Global tuberculosis report 2023 [Internet]. World Health Organization. 2023 [cited 2023 Aug 4]. Available from: https://iris.who.int/;%202023
Kementrian Kesehatan RI. Laporan program penanggulangan tuberkulosis tahun 2022. Jakarta: Kementrian Kesehatan RI, 2023.
Dinas Kesehatan Kota Depok. Profil kesehatan Kota Depok tahun 2022. Depok: Dinas Kesehatan Kota Depok, 2023.
Sinuraya RK, Destiani DP, Puspitasari IM, Diantini A. Medication adherence among hypertensive patients in primary healthcare in Bandung City. Indonesian Journal of Clinical Pharmacy. 2018;7(2):124–33.
Berlowitz DR, Foy CG, Kazis LE, Bolin LP, Conroy MB, Fitzpatrick P, et al. Effect of intensive blood-pressure treatment on patient-reported outcomes. New England Journal of Medicine. 2017;377(8):733–44.
Dogah E, Aviisah M, Kuatewo DAM, Kpene GE, Lokpo SY, Edziah FS. Factors influencing adherence to tuberculosis treatment in the Ketu North District of the Volta Region, Ghana. Tuberc Res Treat. 2021;2021:6685039.
Krasniqi S, Jakupi A, Daci A, Tigani B, Jupolli-Krasniqi N, Pira M, et al. Tuberculosis treatment adherence of patients in Kosovo. Tuberc Res Treat. 2017;2017:4850324.
Amala A, Cahyati WH. Drop out pengobatan pada tuberkulosis multidrug resistant (TB MDR) di Kota Semarang. Quality : Jurnal Kesehatan. 2021;15(1):24–36.
Hassani S, Mohammadi Shahboulagi F, Foroughan M, Nadji SA, Tabarsi P, Ghaedamini Harouni G. Factors associated with medication adherence in elderly individuals with tuberculosis: A qualitative study. Canadian Journal of Infectious Diseases and Medical Microbiology. 2023;2023:4056548.
Laili FN, Octavia DR, Muhtaromah M. Hubungan kepatuhan pengobatan TB-RO terhadap outcome terapi pasien tuberkulosis di Rumah Sakit Muhammadiyah Lamongan. Jurnal Sains dan Kesehatan. 2023;5(5):659–65.
Iskandar D, Suryanegara FDA, van Boven JFM, Postma MJ. Clinical pharmacy services for tuberculosis management: A systematic review. Frontiers in Pharmacology. 2023;14:1186905.
Oh AL, Makmor-Bakry M, Islahudin F, Wong ICK. Prevalence and predictive factors of tuberculosis treatment interruption in the Asia region: A systematic review and meta-analysis. BMJ Glob Health. 2023;8(1):e010592.
Bress AP, Bellows BK, King JB, Hess R, Beddhu S, Zhang Z, et al. Cost-effectiveness of intensive versus standard blood-pressure control. New England Journal of Medicine. 2017;377(8):745–55.
Asgedom SW, Teweldemedhin M, Gebreyesus H. Prevalence of multidrug-resistant tuberculosis and associated factors in Ethiopia: A systematic review. J Pathog. 2018;2018:7104921.
Adiwinata R, Rasidi J, Marpaung M, Sakit Umum Daerah dr Kanujoso Djatiwibowo R, Timur K. Profil klinis dan evaluasi pengobatan pasien rifampicin-resistant dan multidrug-resistant tuberculosis di RSUD dr. Kanujoso Djatiwibowo Balikpapan. J Respir Indo. 2018;38(3):135–42.
Downloads
Additional Files
Published
Issue
Section
License
- The authors own the copyright of published articles. Nevertheless, Jurnal Respirologi Indonesia has the first-to-publish license for the publication material.
- Jurnal Respirologi Indonesia has the right to archive, change the format and republish published articles by presenting the authors’ names.
- Articles are published electronically for open access and online for educational, research, and archiving purposes. Jurnal Respirologi Indonesia is not responsible for any copyright issues that might emerge from using any article except for the previous three purposes.
